The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway

The authors declared no competing interests for this work. Table S1 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.